Literature DB >> 6762901

Some direct and reflex cardiovascular actions of prostacyclin (PGI2) and prostaglandin E2 in anaesthetized dogs.

D J Chapple, G J Dusting, R Hughes, J R Vane.   

Abstract

1 The aim of the study was to determine the mechanism of the hypotension and bradycardia produced by prostacyclin (PGI2). 2 Haemodynamic studies were carried out in nineteen open-chest beagle dogs anaesthetized with chloralose. PGI2 was infused intravenously or into the left atrium. 3 Infusions of PGI2 either intravenously or into the left atrium equally reduced arterial pressure and total peripheral resistance but bradycardia was greater after infusion into the left atrium. 4 Comparison of effects of PGI2 with those of prostaglandin E2 (PGE2) showed that although left atrial infusions both reduced aortic pressure and total peripheral resistance, PGE2 always increased heart rate, cardiac output and maximum acceleration. 5 Similar effects were observed with sodium nitroprusside except that it always caused tachycardia and reduced stroke volume. 6 Atropine (0.05 or 1 mg/kg i.v.) reduced or reversed the bradycardia induced by PGI2 but its hypotensive effects were reduced only after 1 mg/kg atropine. After vagotomy changes in cardiac output, stroke volume and maximum acceleration were increased, the hypotensive effects of PGI2 were reduced and the bradycardia was reversed; effects induced by PGE2 were not significantly altered. 7 The hypotension induced by prostacyclin is due to two components, a direct relaxation of vascular smooth muscle and a reflex, non-cholinergic vasodilatation. The bradycardia is reflex in nature and is partially mediated by the vagus pathway.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6762901      PMCID: PMC2044201          DOI: 10.1111/j.1476-5381.1980.tb14557.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Stimulation of 'irritant' receptors and afferent C-fibres in the lungs by prostaglandins.

Authors:  H M Coleridge; J C Coleridge; K H Ginzel; D G Baker; R B Banzett; M A Morrison
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

2.  Effects of ganglionic and beta-adrenergic blockade on cardiovascular responses to the bisenoic prostaglandins and their precursor arachidonic acid.

Authors:  P A Kot; M Johnson; P W Ramwell; J C Rose
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

3.  Synthesis and sterochemistry of prostacyclin and synthesis of 6-ketoprostagliandin F1alpha.

Authors:  R A Johnson; F H Lincoln; J L Thompson; E G Nidy; S A Mizak; U Axen
Journal:  J Am Chem Soc       Date:  1977-06-08       Impact factor: 15.419

4.  Cardiovascular actions of prostacyclin (PCI2) in chloralose anaesthetized dogs [proceedings].

Authors:  J M Armstrong; D Chapple; G J Dusting; R Hughes; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

5.  The effect of haemodynamic changes on maximum blood flow acceleration at the aortic root in the anaesthetized, open-chest dog.

Authors:  D C Chung; J H Chamberlain; R G Seed
Journal:  Cardiovasc Res       Date:  1974-05       Impact factor: 10.787

6.  Cardiovascular actions of prostaglandin C in the cat and dog.

Authors:  R L Jones; K A Kane; A Ungar
Journal:  Br J Pharmacol       Date:  1974-06       Impact factor: 8.739

7.  Continuous measurement of peripheral vascular resistance and circulatory function.

Authors:  R Hughes
Journal:  Med Biol Eng       Date:  1971-11

8.  Prostaglandins: their disappearance from and release into the circulation.

Authors:  S H Ferreira; J R Vane
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

9.  Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.

Authors:  S Bunting; R Gryglewski; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1976-12

10.  Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-01
View more
  12 in total

1.  Inhibition of cyclooxygenase attenuates baroreceptor function and increases the pressor response to norepinephrine in man.

Authors:  B Weisser; G Kayser; S Wagner; B O Göbel; H Vetter; R Düsing
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Rapid and simultaneous quantitation of prostanoids by UPLC-MS/MS in rat brain.

Authors:  Jafar Sadik B Shaik; Tricia M Miller; Steven H Graham; Mioara D Manole; Samuel M Poloyac
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

3.  The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.

Authors:  G Allan; M J Follenfant; P Lidbury; P L Oliver; B J Whittle
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

4.  Prostacyclin can either increase or decrease heart rate depending on the basal state.

Authors:  M Chiavarelli; S Moncada; K M Mullane
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

5.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

6.  Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis.

Authors:  M P Fink; T J MacVittie; L C Casey
Journal:  Ann Surg       Date:  1984-11       Impact factor: 12.969

7.  The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.

Authors:  S Hassan; H Pickles; A Fish; C Burke; S Warrington; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

8.  Mechanisms of reflex bradycardia and hypotension by metabolites of arachidonic acid in the cat.

Authors:  T H Hintze; G Kaley; M J Panzenbeck
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

9.  Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483.

Authors:  E Totsuka; S Todo; Y Zhu; N Ishizaki; Y Kawashima; M B Jin; A Urakami; T Shimamura; T E Starzl
Journal:  J Am Coll Surg       Date:  1998-09       Impact factor: 6.113

10.  Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog hearts.

Authors:  J Scholtholt; H Birringer; V B Fiedler; B Schölkens
Journal:  Basic Res Cardiol       Date:  1981 May-Jun       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.